We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-2.72%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$96.6M
AUM Growth
+$3.23M
Cap. Flow
-$3.56M
Cap. Flow %
-3.68%
Top 10 Hldgs %
100%
Holding
9
New
–
Increased
–
Reduced
–
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
OCUL icon
Ocular Therapeutix
OCUL
+$3.56M

Sector Composition

Rank Sector Weight
1 Healthcare 93.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RNAC icon
1
Cartesian Therapeutics
RNAC
$218M
$38.2M 39.54%
64,138
– –
DARE icon
2
Dare Bioscience
DARE
$17.4M
$14.6M 15.1%
27,396
– –
GNCA
3
DELISTED
Genocea Biosciences, Inc.
GNCA
$10.3M 10.63%
246,076
– –
PULM icon
4
Pulmatrix
PULM
$6.1M
$8.59M 8.89%
18,040
– –
FATE icon
5
Fate Therapeutics
FATE
$275M
$8.01M 8.29%
2,473,186
– –
ATYR
6
aTyr Pharma
ATYR
$47.4M
$6.21M 6.43%
130,571
– –
TTOO
7
DELISTED
T2 Biosystems, Inc
TTOO
$6.02M 6.23%
375
– –
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$4.72M 4.89%
3,286
– –
OCUL icon
9
Ocular Therapeutix
OCUL
$1.83B
– –
-383,141
Closed -$3.56M

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q2 2017 Portfolio in Review

As of Q2 2017, Polaris Venture Management Co V held 9 positions worth $96.6M, up 3.5% from $93.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V withdrew a net $3.56M in Q2 2017, closing 1 position. Its most notable exit was Ocular Therapeutix, an estimated $3.56M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 89% a quarter earlier.

  • Polaris Venture Management Co V fully exited Ocular Therapeutix in Q2 2017, selling an estimated $3.56M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $96.6M portfolio in Q2 2017.
  • Polaris Venture Management Co V opened 0 new positions and closed 1 in Q2 2017.
  • Polaris Venture Management Co V's portfolio value rose 3.5% quarter-over-quarter to $96.6M.

Based on Polaris Venture Management Co V's 13F filing for Q2 2017, filed 14 Aug 2017.